| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer
|
Loft, Matthew
|
|
|
198 |
1 |
p. 67-74
|
artikel
|
| 2 |
Adjuvant chemotherapy in patients with ER-negative/HER2-negative, T1abN0 breast cancer: a nationwide study
|
Hassing, Christina M. S.
|
|
|
198 |
1 |
p. 103-112
|
artikel
|
| 3 |
A propensity score–weighted study comparing a two- versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer
|
Bischoff, H.
|
|
|
198 |
1 |
p. 23-29
|
artikel
|
| 4 |
A rare but persistent cause of decreased function secondary to adjuvant radiation therapy in women with breast cancer
|
Harris, Susan R.
|
|
|
198 |
1 |
p. 185-186
|
artikel
|
| 5 |
A retrospective study in tumour characteristics and clinical outcomes of overweight and obese women with breast cancer
|
Luís, Carla
|
|
|
198 |
1 |
p. 89-101
|
artikel
|
| 6 |
Assessing the role of tumour-associated macrophage subsets in breast cancer subtypes using digital image analysis
|
Zwager, Mieke C.
|
|
|
198 |
1 |
p. 11-22
|
artikel
|
| 7 |
Association between patient–surgeon race and gender concordance and patient-reported outcomes following breast cancer surgery
|
Hassan, Abbas M.
|
|
|
198 |
1 |
p. 167-175
|
artikel
|
| 8 |
Bioimpedance spectroscopy for breast cancer-related lymphedema assessment: clinical practice guidelines
|
Shah, Chirag
|
|
|
198 |
1 |
p. 1-9
|
artikel
|
| 9 |
Clinical impact of MRI-detected additional lesions in breast cancer patients with neoadjuvant systemic therapy at the Netherlands cancer institute
|
van Loevezijn, Ariane A.
|
|
|
198 |
1 |
p. 131-141
|
artikel
|
| 10 |
Comparison of breast cancer HER-2 receptor testing with immunohistochemistry and in situ hybridization
|
Shanmugalingam, Aswin
|
|
|
198 |
1 |
p. 143-148
|
artikel
|
| 11 |
Disparities in the use of assisted reproductive technologies after breast cancer: a population-based study
|
Meernik, Clare
|
|
|
198 |
1 |
p. 149-158
|
artikel
|
| 12 |
Early effectiveness and toxicity outcomes of reirradiation after breast conserving surgery for recurrent or new primary breast cancer
|
Hardy-Abeloos, Camille
|
|
|
198 |
1 |
p. 43-51
|
artikel
|
| 13 |
Genetic testing in privately insured women with surgically treated breast cancer
|
Dinan, Michaela A.
|
|
|
198 |
1 |
p. 177-181
|
artikel
|
| 14 |
Impact of CDK4/6 inhibitors on chemotherapy utilization in earlier therapy lines for HR+/HER2– metastatic breast cancer in the United States
|
Goyal, Ravi K.
|
|
|
198 |
1 |
p. 159-166
|
artikel
|
| 15 |
Possible mechanism behind the association between disrupted sleep quality and breast cancer outcome
|
Altundag, Kadri
|
|
|
198 |
1 |
p. 183
|
artikel
|
| 16 |
Pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis and treatment outcomes with non-pregnant patients
|
Tan, Qing Ting
|
|
|
198 |
1 |
p. 53-66
|
artikel
|
| 17 |
Preventing metastatic recurrence in low-risk ER/PR + breast cancer patients—a retrospective clinical study exploring the evolving challenge of persistence with adjuvant endocrine therapy
|
Kuhn, Elaine P.
|
|
|
198 |
1 |
p. 31-41
|
artikel
|
| 18 |
Racial disparities in overall survival after the introduction of cyclin-dependent kinase 4/6 inhibitors for patients with hormone receptor-positive, HER2-negative metastatic breast cancer
|
Alvarez, Alvaro
|
|
|
198 |
1 |
p. 75-88
|
artikel
|
| 19 |
The association of trastuzumab with atrial fibrillation and heart failure in breast cancer patients in routine clinical practice: a population-based propensity score matching and competing risk model analysis
|
Wu, Wen-Chi
|
|
|
198 |
1 |
p. 113-122
|
artikel
|
| 20 |
Time interval between diagnosis to treatment of breast cancer and the impact of health insurance coverage: a sub analysis of the AMAZONA III Study (GBECAM 0115)
|
Maschmann, Raíra Mesquita
|
|
|
198 |
1 |
p. 123-130
|
artikel
|
Tijdschrift beschrijving